Advertisement
Advertisement
KPTI
Karyopharm Therapeutics Inc.
9.54
USDSponsored
+0.42
+4.55%
Jun 25, 11:11 UTC -4
Open
KPTI Earnings Reports
Positive Surprise Ratio
KPTI beat 25 of 42 last estimates.
60%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$33.78M
/-$1.33
Implied change from Q1 26 (Revenue/ EPS)
-3.66%
/+30.39%
Implied change from Q2 25 (Revenue/ EPS)
-10.94%
/-69.21%
Karyopharm Therapeutics Inc. earnings per share and revenue
On May 14, 2026, KPTI reported earnings of -1.02 USD per share (EPS) for Q1 26, beating the estimate of -1.45 USD, resulting in a 30.00% surprise. Revenue reached 35.07 million, compared to an expected 32.03 million, with a 9.49% difference. The market reacted with a +0.56% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -1.33 USD, with revenue projected to reach 33.78 million USD, implying an increase of 30.39% EPS, and decrease of -3.66% in Revenue from the last quarter.
FAQ
What were Karyopharm Therapeutics Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Karyopharm Therapeutics Inc. reported EPS of -$1.02, beating estimates by 30%, and revenue of $35.07M, 9.49% above expectations.
How did the market react to Karyopharm Therapeutics Inc.'s Q1 2026 earnings?
The stock price moved up 0.56%, changed from $8.85 before the earnings release to $8.90 the day after.
When is Karyopharm Therapeutics Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Karyopharm Therapeutics Inc.'s next earnings report?
Based on 5
analysts, Karyopharm Therapeutics Inc. is expected to report EPS of -$1.33 and revenue of $33.78M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement